Mortality and morbidity risks vary with birth weight standard deviation score in growth restricted extremely preterm

Takuji Yamakawa1, Kazuo Itabashi1, Satoshi Kusuda2

  • 1Department of Pediatrics, Showa University School of Medicine, Tokyo, Japan.

Early Human Development
|November 30, 2015
PubMed

Insights

Growth restriction in extremely preterm infants increases mortality and morbidity risks, with outcomes varying by birth weight standard deviation score (BWSDS). Lower BWSDS indicates higher risks for conditions like chronic lung disease and sepsis.

Area of Science:

  • Neonatalogy
  • Perinatal Medicine
  • Pediatric Research

Background:

  • Extremely preterm infants (<28 weeks gestation) often experience growth restriction.
  • Birth weight standard deviation score (BWSDS) quantifies deviation from expected fetal growth.
  • Understanding risks associated with varying degrees of growth restriction is crucial for neonatal care.

Purpose of the Study:

  • To investigate the association between birth weight standard deviation score (BWSDS) and mortality and morbidity in growth-restricted extremely preterm infants.
  • To determine if the risks of adverse outcomes differ across various categories of BWSDS.

Main Methods:

  • Multicenter retrospective cohort study involving 9149 infants born between 2003-2010 at <28 weeks gestation.
  • Infants categorized into groups based on BWSDS: <-2.0, -2.0 to -1.5, -1.5 to -1.0, -1.0 to -0.5, and ≥-0.5 (non-growth restricted).
  • Statistical analysis adjusted for covariates to assess risks of mortality and morbidities.

Main Results:

  • Adjusted analyses revealed significant differences in mortality and morbidity risks across BWSDS groups.
  • Infants with BWSDS -1.5 to <-1.0 showed increased adjusted odds ratios (aOR) for mortality (1.69) and chronic lung disease (CLD) (1.28).
  • Higher risks for severe retinopathy of prematurity (ROP) (aOR, 1.36) and sepsis (aOR, 1.72) were observed in infants with BWSDS -2.0 to <-1.5.
  • A BWSDS <-2.0 was associated with a significantly increased aOR for necrotizing enterocolitis (NEC) (2.41).

Conclusions:

  • Growth restriction in extremely preterm infants is linked to elevated risks of mortality and specific morbidities, including CLD, ROP, sepsis, and NEC.
  • The magnitude of these risks appears to be dependent on the degree of growth restriction, as indicated by BWSDS.
  • These findings highlight the importance of considering BWSDS when assessing and managing risks in this vulnerable population.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
462
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
1.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
704